The APMAP/EGFR axis enhances cholesterol-induced EMT in prostatic carcinoma (35), and APMAP promotes metastasis of cervical cancer by activating the Wnt/β-catenin pathway (36). This evidence concerns the gene APMAP and cervical carcinoma.